Join us on April 23rd for our 2025 Global Metals & Minerals Project Spending Outlook! RSVP Today!
Sales & Support: +1 800 762 3361
For more information call: +1 800 762 3361

COVID-19 Stops Non-Essential Pharma-Bio Capex Projects in California, Pennsylvania, an Industrial Info Market Brief

COVID-19 Stops Non-Essential Pharma-Bio Capex Projects in California, Pennsylvania, an Industrial Info Market Brief

While the Pharma-Bio Industry is classified as an essential industry in the era of COVID-19, it is becoming apparent that a number of big-ticket projects are being shut down. California and Pennsylvania were the first two states to issue stay-in-place orders, and it soon became clear that non-essential large capex projects had ground to a halt.

In California, Bayer shut down its $150 million cell culture tech center in Berkeley, as did Cytokinetics and its $200 million project in South San Francisco.

Login or Register for Instant Access

Subscribe Now!

(All Fields Required)

×
Contact Us

For More Info!